Form 4 GERON CORP For: Jun 06 Filed by: Kapur Anil
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/23/2026
- Wall St dips after AI-led selloff; SpaceX worries hit telecoms
- Meta's capital-raising plans expose a major weakness in the AI boom
- Brent crude hits more than five-month high on Houthi-Saudi attacks, UAE oil spill
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
- AMD shares fall amid AI chip sector selloff
- JetBlue shares fall amid American results, fuel cost concerns
- Bloom Energy Corp. (BE) Tops Q3 EPS by 25c, Beats on Revenue; Offers FY26 Guidance
- S&P 500, Nasdaq end sharply lower as revived AI doubts ignite tech selloff
- Nokia shares fall despite earnings beat on cash flow concerns
Geron Corporation (GERN) PT Raised to $6 at Goldman Sachs
June 10, 2024 11:59 AM EDTGoldman Sachs analyst Corinne Jenkins raised the price target on Geron Corporation (NASDAQ: GERN) to $6.00 (from $5.00) while maintaining a Buy rating.
The analyst comments "GERN is trading +19.7% (vs. -1.6% for the XBI) intraday following the FDA approval of Rytelo (imetelstat) in lower-risk myelodysplastic syndrome (LR-MDS).... More



